Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionBurney Co/
Latest Disclosed Ownership24,708 shares
Latest Disclosed Value $ 1,498,516
Burney Co/ reports 61.16% decrease in ownership of BRM / Bristol-Myers Squibb Company

On April 29, 2026 - Burney Co/ filed a 13F-HR form disclosing ownership of 24,708 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,295,193 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 63,621 shares of Bristol-Myers Squibb Company. This represents a change in shares of -61.16% during the quarter. The current value of the position is $1,172,024 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 24,708 -38,913 -61.16 1,499 -56.34 0.0469
2026-01-23 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 63,621 53,141 507.07 3,432 626.91 0.1070
2025-10-16 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 10,480 -312 -2.89 473 -5.41 0.0150
2025-08-05 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 10,792 -1,576 -12.74 500 -33.82 0.0169
2025-05-06 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 12,368 -385 -3.02 754 4.58 0.0274
2025-01-14 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 12,753 516 4.22 721 13.90 0.0255
2024-10-18 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 12,237 -1,534 -11.14 633 10.86 0.0225
2024-07-29 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 13,771 -345 -2.44 572 -25.36 0.0219
2024-05-22 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 14,116 -347 -2.40 766 3.10 0.0292
2024-02-12 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 14,463 -10,703 -42.53 742 -49.18 0.0312
2023-11-08 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 25,166 -34,140 -57.57 1,461 -61.50 0.0684
2023-08-09 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 59,306 46,858 376.43 3,793 339.91 0.1739
2023-05-10 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 12,448 20 0.16 863 -3.58 0.0425
2023-02-06 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 12,428 -230 -1.82 894 -0.67 0.0453
2022-11-15 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 12,658 -67 -0.53 900 -8.16 0.0497
2022-08-12 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 12,725 -400 -3.05 980 2.19 0.0516
2022-05-09 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 13,125 -221 -1.66 959 15.26 0.0394
2022-02-11 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 13,346 -549 -3.95 832 1.22 0.0359
2021-11-12 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 13,895 184 1.34 822 -10.26 0.0386
2021-08-06 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 13,711 -154 -1.11 916 4.69 0.0426
2021-05-13 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 13,865 876 6.74 875 8.56 0.0432
2021-02-11 2020-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 12,989 -1,764 -11.96 806 -9.44 0.0442
2020-12-14 2020-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 14,753 -11,260 -43.29 890 -41.79 0.0551
2020-08-13 2020-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 26,013 -12,093 -31.74 1,529 -28.01 0.0992
2020-05-13 2020-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 38,106 -66,469 -63.56 2,124 -68.36 0.1632
2020-02-14 2019-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 104,575 96,446 1,186.44 6,713 1,529.37 0.3700
2019-11-12 2019-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 8,129 -496 -5.75 412 5.37 0.0247
2019-08-12 2019-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 8,625 -1,000 -10.39 391 -14.81 0.0237
2019-05-13 2019-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 9,625 -380 -3.80 459 -11.73 0.0284
2019-02-12 2018-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 10,005 894 9.81 520 -8.13 0.0366
2018-11-13 2018-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 9,111 -4,228 -31.70 566 -23.31 0.0337
2018-08-13 2018-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 13,339 -214 -1.58 738 -13.89 0.0432
2018-05-08 2018-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 13,553 -1,049 -7.18 857 -4.25 0.0531
2018-02-13 2017-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 14,602 1,150 8.55 895 5.54 0.0506
2017-11-13 2017-09-30 13F/A-1 Bristol-Myers Squibb COM 110122108 13,452 -8,212 -37.91 848 -29.86 0.0551
2017-11-09 2017-09-30 13F Bristol-Myers Squibb COM 110122108 21,664 0 1,209
2017-08-09 2017-06-30 13F Bristol-Myers Squibb COM 110122108 21,664 5,735 36.00 1,209 39.61 0.0792
2017-05-11 2017-03-31 13F Bristol-Myers Squibb COM 110122108 15,929 8,175 105.43 866 91.17 0.0571
2017-02-07 2016-12-31 13F Bristol-Myers Squibb COM 110122108 7,754 -572 -6.87 453 -1.31 0.0308
2016-11-14 2016-09-30 13F Bristol-Myers Squibb COM 110122108 8,326 577 7.45 459 -19.47 0.0324
2016-08-10 2016-06-30 13F Bristol-Myers Squibb COM 110122108 7,749 -72 -0.92 570 14.00 0.0409
2016-05-02 2016-03-31 13F Bristol-Myers Squibb COM 110122108 7,821 -535 -6.40 500 -13.49 0.0364
2016-02-09 2015-12-31 13F Bristol-Myers Squibb COM 110122108 8,356 0 0.00 578 16.77 0.0428
2015-11-03 2015-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 8,356 524 6.69 495 -4.99 0.0381
2015-08-10 2015-06-30 13F Bristol-Myers Squibb COM 110122108 7,832 -835 -9.63 521 -6.80 0.0354
2015-05-12 2015-03-31 13F Bristol-Myers Squibb COM 110122108 8,667 100 1.17 559 10.47 0.0383
2015-02-11 2014-12-31 13F BRISTOL COM 110122108 8,567 -600 -6.55 506 7.89 0.0401
2014-11-12 2014-09-30 13F BRISTOL COM 110122108 9,167 295 3.33 469 9.07 0.0402
2014-08-05 2014-06-30 13F/A-1 BRISTOL COM 110122108 8,872 100 1.14 430 -5.70 0.0372
2014-08-04 2014-06-30 13F BRISTOL COM 110122108 8,872 430
2014-05-07 2014-03-31 13F/A-1 BRISTOL COM 110122108 8,772 -889 -9.20 456 -11.11 0.0415
2014-05-06 2014-03-31 13F BANK OF HAW COM 110122108 3,550 215
2014-02-03 2013-12-31 13F BRISTOL COM 110122108 9,661 -629 -6.11 513 7.77 0.0499
2013-11-04 2013-09-30 13F BRISTOL COM 110122108 10,290 -2,734 -20.99 476 -18.21 0.0532
2013-07-22 2013-06-30 13F BRISTOL COM 110122108 13,024 13,024 582 0.0727
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.